Radiation Oncology/Therapy: Page 18

ITM secures supply deal with Clovis Oncology

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich has signed an agreement to supply its EndolucinBeta no-carrier-added lutetium-177 radiopharmaceutical precursor to Clovis Oncology.

October 18, 2021

Molecular firms sign European agreement on isotopes

By AuntMinnieEurope.com staff writers

Israeli radiopharmaceutical firm Isotopia Molecular Imaging and Austria-based Seibersdorf Labor have signed a production agreement for lutetium-177 (Lu-177), which is used to manufacture radioisotopes for cancers including neoendocrine and prostate.

October 17, 2021

Sirtex announces 1st administration of yttrium-90 microspheres in China

By AuntMinnieEurope.com staff writers

Radiation oncology firm Sirtex Medical is highlighting the successful first administration of its SIR-Spheres yttrium-90 resin microspheres in China.

October 13, 2021

Swiss hospital combines RaySearch, Accuray rad therapy

By AuntMinnieEurope.com staff writers

RaySearch Laboratories said the Vaud University Hospital Center in Lausanne, Switzerland, is the first center in the world to treat a patient using the RayStation radiation therapy planning system in conjunction with the Accuray CyberKnife treatment delivery system.

September 30, 2021

Theragnostics enters licensing deal with AAA for Ga-68 PET

By AuntMinnieEurope.com staff writers

Theragnostics has signed a global licensing agreement with Advanced Accelerator Applications (AAA) to develop and commercialize gallium-68 (Ga-68) one-step PET radiopharmaceuticals.

September 26, 2021

IBA, SCK CEN sign actinium-225 deal

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) and Belgian nuclear research center SCK CEN have partnered to enable the production of the medical radioisotope actinium-225.

September 14, 2021

Swiss group underlines potential benefits of second-look PET/CT

By Will Morton

Investigators from Bern in Switzerland think a second PET/CT scan is worthwhile before radiotherapy treatment, especially when delays of over four weeks occur after initial scans in patients with advanced head and neck squamous cell cancer.

September 14, 2021

Accuray promotes prostate cancer research at ESTRO 2021

By AuntMinnieEurope.com staff writers

Radiation oncology firm Accuray is highlighting research presented at the recent European Society for Radiotherapy and Oncology (ESTRO) annual congress on the benefits of its CyberKnife robotic radiotherapy platform in prostate cancer treatment.

September 13, 2021

Elekta acquires Turkish distributor

By AuntMinnieEurope.com staff writers

Radiation oncology firm Elekta has acquired its Turkish distributor, Özyürek Mümessillik ve DıŞ Ticaret. The move will improve Elekta's market access in the region and strengthen its relationship with customers, the company said.

September 2, 2021

Elekta to establish foundation to improve cancer care access

By AuntMinnieEurope.com staff writers

Radiation oncology firm Elekta is establishing the Elekta Foundation to support projects in low- and middle-income countries to improve access to cancer care.

August 26, 2021

IBA, partners commence proton therapy clinical trial

By AuntMinnieEurope.com staff writers

Proton therapy developer Ion Beam Applications (IBA) is teaming up with 19 industry and academic partners on ProtectTrial, a large-scale clinical trial in Europe to assess the use of proton therapy in treating esophageal cancer.

August 23, 2021

Imaging Endpoints opens new European office

By AuntMinnieEurope.com staff writers

Contract research organization Imaging Endpoints has opened a new European office in Basel, Switzerland.

August 9, 2021

Previous Page

Page 18 of 129

Next Page